Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BiomeSense logo — Developing novel tools to enable the routine, low-cost analy...

BiomeSense

Developing novel tools to enable the routine, low-cost analysis of human microbiome data.

Founded 2018 United States Chicago, United States 15 employees Series Unknown Total: $12.61M Analytics, Biotechnology +3

General Information

Company Name BiomeSense
Founded Year 2018
Location United States Chicago, United States +1
Employees 15
Industries Analytics, Biotechnology, Health Care +2
Funding Stage Series Unknown
Social

Get notified when BiomeSense moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BiomeSense

BiomeSense is a groundbreaking startup in the biotech and health care industries, aiming to revolutionize human microbiome research. The company's slogan, "Developing novel tools to enable the routine, low-cost analysis of human microbiome data." succinctly captures its mission. Founded in 2018 and headquartered in the United States, BiomeSense has attracted significant attention with its recent $6.18M Venture Round investment in December 2023. The company's innovative approach involves creating tools to track, analyze, and store daily microbiome profiles of clinical trial participants. This pioneering method provides a wealth of data at a fraction of the current cost, offering investigators unprecedented insight into the intricate relationship between the microbiome and clinical interventions. BiomeSense's disruptive technology has the potential to significantly advance human microbiome research, with implications for various aspects of healthcare and beyond. In the rapidly evolving landscape of biotechnology and health care analytics, BiomeSense's approach holds promise for transforming the way we understand and utilize microbiome data. As the company continues to attract significant investments, it is poised to make a substantial impact on the field and potentially shape the future of human microbiome research.

Taxonomy: microbiome research, data analysis tools, clinical trials, biome profiling, microbiome influence, clinical interventions

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 19 Dec 2023
Seed Round •••••• 7
Investor Investor Investor Investor Investor Investor Investor
05 Feb 2023
Seed Round •••••• 1
Investor
04 Feb 2022
Convertible Note •••••• - 01 Sep 2021
Convertible Note •••••• 1
Investor
02 Jun 2021

View All 11 Funding Rounds

Latest News

View All
Bluestein Ventures raises $45M for third food tech fund — Techcrunch
Bluestein Ventures raises $45M for third food tech fund
Techcrunch Feb 20, 2024

BiomeSense Alternatives & Competitors

BiomeSense vs
Sequential - The Skin Microbiome Testing Co™
Sequential - The Skin Microbiome Testing Co™ United States

The Skin Microbiome Testing Co.™

Seed
18 employees
Health Care, Wellness Beauty
BiomeSense vs
Microbiome Research Pvt Ltd
Microbiome Research Pvt Ltd India

Our focus is on detailed understanding of the ‘invisible microbial life’ inside all of us.

16 employees
Education, Health and Wellness
BiomeSense vs
Finch Therapeutics
Finch Therapeutics

Finch Therapeutics has a portfolio of microbiome assets including CP101, a late-stage, investigation...

Series D
20 employees
Biotechnology, Health and Wellness

FAQ About BiomeSense

Developing novel tools to enable the routine, low-cost analysis of human microbiome data.
BiomeSense was founded in 2018.
BiomeSense is headquartered in Chicago, United States.
BiomeSense operates in the following industries: Analytics, Biotechnology, Health Care, Life Sciences, Clean Energy.
BiomeSense has approximately 15 employees.
BiomeSense has completed 11 funding rounds, raising a total of $12.61M. The latest funding stage is Series Unknown.
Top alternatives and competitors to BiomeSense include Sequential - The Skin Microbiome Testing Co™, Microbiome Research Pvt Ltd, Finch Therapeutics, CC Bio, Microbiotica . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BiomeSense and Sequential - The Skin Microbiome Testing Co™ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BiomeSense and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy